Nu Skin Enterprises (NYSE:NUS) Updates FY 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 0.700-0.900 for the period, compared to the consensus EPS estimate of 1.000. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Nu Skin Enterprises also updated its Q3 2026 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Stock Down 6.0%

Shares of NYSE:NUS opened at $5.16 on Tuesday. The company’s fifty day moving average is $5.21 and its 200-day moving average is $6.94. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.34 and a current ratio of 2.03. Nu Skin Enterprises has a 52 week low of $4.89 and a 52 week high of $14.62. The company has a market capitalization of $250.52 million, a PE ratio of 4.69 and a beta of 0.98.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Sunday, August 9th. The company reported $0.20 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.20. The business had revenue of $320.11 million during the quarter, compared to analysts’ expectations of $345.20 million. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. Equities research analysts predict that Nu Skin Enterprises will post 1 earnings per share for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 9th. Stockholders of record on Friday, August 28th will be paid a $0.06 dividend. The ex-dividend date is Friday, August 28th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 4.7%. Nu Skin Enterprises’s payout ratio is 21.82%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on NUS shares. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Weiss Ratings downgraded Nu Skin Enterprises from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, June 4th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Trending Headlines about Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Nu Skin declared a quarterly cash dividend of $0.06 per share, payable September 9 to shareholders of record on August 28. The dividend provides ongoing income support, although the payout is modest relative to the company’s operating challenges. Nu Skin Enterprises Announces Quarterly Dividend
• Neutral Sentiment: Nu Skin’s adjusted second-quarter EPS of $0.20 matched consensus estimates, but this was sharply below $0.43 a year earlier. The company’s reported loss included substantial non-cash impairment and tax charges, producing diluted GAAP EPS of negative $5.14. Nu Skin Enterprises Matches Q2 Earnings Estimates
• Negative Sentiment: Second-quarter revenue fell 17.1% year over year to $320.1 million, below analyst expectations of roughly $345 million-$349 million. Customers declined 14% to 660,037, while paid affiliates fell 8% and sales leaders dropped 9%, signaling continued weakness in the company’s sales network. Nu Skin Enterprises Reports Second Quarter Results
• Negative Sentiment: Management’s outlook was also below expectations: third-quarter EPS guidance of $0.10-$0.20 trailed the $0.32 consensus estimate, and revenue guidance of $310 million-$340 million was below the $375.5 million forecast. Full-year EPS guidance of $0.70-$0.90 likewise lagged the $1.00 consensus, increasing concerns about near-term earnings momentum.

Institutional Investors Weigh In On Nu Skin Enterprises

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Graham Capital Management L.P. boosted its holdings in Nu Skin Enterprises by 7.7% in the fourth quarter. Graham Capital Management L.P. now owns 28,955 shares of the company’s stock valued at $279,000 after acquiring an additional 2,077 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after purchasing an additional 2,614 shares during the period. Russell Investments Group Ltd. boosted its stake in shares of Nu Skin Enterprises by 2.5% in the 4th quarter. Russell Investments Group Ltd. now owns 110,850 shares of the company’s stock valued at $1,066,000 after purchasing an additional 2,738 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of Nu Skin Enterprises by 3.7% in the 2nd quarter. Rhumbline Advisers now owns 80,119 shares of the company’s stock valued at $640,000 after purchasing an additional 2,856 shares during the last quarter. Finally, Amundi grew its position in shares of Nu Skin Enterprises by 18.8% during the 1st quarter. Amundi now owns 18,564 shares of the company’s stock worth $127,000 after buying an additional 2,941 shares during the period. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.